Interplay between TRAP1 and Sirtuin-3 Modulates Mitochondrial Respiration and Oxidative Stress to Maintain Stemness of Glioma Stem Cells.
Hye-Kyung ParkJun-Hee HongYoung Taek OhSung Soo KimJinlong YinAn-Jung LeeYoung Chan ChaeJong Heon KimByoung Heon KangPublished in: Cancer research (2019)
Glioblastoma (GBM) cancer stem cells (CSC) are primarily responsible for metastatic dissemination, resistance to therapy, and relapse of GBM, the most common and aggressive brain tumor. Development and maintenance of CSCs require orchestrated metabolic rewiring and metabolic adaptation to a changing microenvironment. Here, we show that cooperative interplay between the mitochondrial chaperone TRAP1 and the major mitochondria deacetylase sirtuin-3 (SIRT3) in glioma stem cells (GSC) increases mitochondrial respiratory capacity and reduces production of reactive oxygen species. This metabolic regulation endowed GSCs with metabolic plasticity, facilitated adaptation to stress (particularly reduced nutrient supply), and maintained "stemness." Inactivation of TRAP1 or SIRT3 compromised their interdependent regulatory mechanisms, leading to metabolic alterations, loss of stemness, and suppression of tumor formation by GSC in vivo. Thus, targeting the metabolic mechanisms regulating interplay between TRAP1 and SIRT3 may provide a novel therapeutic option for intractable patients with GBM. SIGNIFICANCE: Discovery and functional analysis of a TRAP1-SIRT3 complex in glioma stem cells identify potential target proteins for glioblastoma treatment.
Keyphrases
- stem cells
- oxidative stress
- cancer stem cells
- reactive oxygen species
- ischemia reperfusion injury
- epithelial mesenchymal transition
- cell therapy
- squamous cell carcinoma
- small cell lung cancer
- dna damage
- diabetic rats
- risk assessment
- cell death
- signaling pathway
- cancer therapy
- endoplasmic reticulum
- bone marrow
- smoking cessation
- free survival